SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.

Dimopoulos, Christina; Al-Bawardy, Badr

Dimopoulos, Christina; Al-Bawardy, Badr.

Dimopoulos C; Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.
Al-Bawardy B; Yale School of Medicine, Section of Digestive Diseases, Yale University, New Haven, Connecticut, USA.

Inflamm Bowel Dis ; 26(12): e153-e154, 2020 11 19.

Article in English | MEDLINE | ID: covidwho-1387888

Subject(s)

Biological Products/therapeutic use; COVID-19/diagnosis; Crohn Disease/therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Young Adult

Keywords

Crohn's disease; SARS-CoV-2; biologic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Crohn Disease / COVID-19 Type of study: Case report / Diagnostic study Limits: Adult / Humans / Male / Young adult Language: English Journal: Inflamm Bowel Dis Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: IBD

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google